Quarterly Result15 May 2026, 12:50 pm
Shree Ganesh Remedies FY26 Revenue Up 1% YoY at ₹109.29 Cr
AI Summary
Shree Ganesh Remedies Ltd reported its Q4 and FY26 financial results. For the year ended March 31, 2026, the company's revenue stood at ₹109.29 Cr, a 1% increase YoY, while EBITDA decreased by 11% to ₹35.02 Cr, and PAT decreased by 23% to ₹17.77 Cr. The company is progressing on CRAMS engagements and expects commercial production from Block 7 expansion to commence in Q2FY27. The management noted FY26 as a year of consolidation, with a focus on strengthening the business foundation.
Key Highlights
- Q4FY26 revenue increased by 36% YoY to ₹33.20 Cr.
- FY26 revenue increased by 1% YoY to ₹109.29 Cr.
- EBITDA for FY26 decreased by 11% YoY to ₹35.02 Cr.
- PAT for FY26 decreased by 23% YoY to ₹17.77 Cr.
- Commercial production from Block 7 expansion expected to commence in Q2FY27.